科研之友
微信
新浪微博
Facebook
分享链接
摘要
<正>1文献来源Baselga J,Im S-A,Iwata H,et al.PIK3CA status in circulating tumor DNA(ct DNA)predicts efficacy of Buparlisib(BUP)plus Fulvestrant(FULV)in postmenopausal women with endocrine-resistant HR+/HER2–advanced breast cancer(BC):First results from the randomized,phaseⅢBELLE-2trial[C].San Antonio Breast Cancer Symposium,2015,abst S6-01.
-
单位广东省医学科学院; 暨南大学附属第一医院; 广东省人民医院
